Pericardiocentesis: Draining the Fluid Compressing the Heart

The Scene

The following scene is drawn from the composite of patients I have cared for in clinic and on the hospital floor. All identifying details are changed.

She was fifty-seven years old and had been deteriorating over four days without knowing why. She came to the emergency department with progressive shortness of breath and a feeling of pressure in her chest that was different from anything she had experienced before. She had a history of breast cancer, treated two years prior, and was currently in remission by her oncologist’s last assessment.

Her blood pressure on arrival was 90/74. Her heart rate was 118. Her oxygen saturation was 94 percent on room air. When I listened to her heart, the sounds were distant, as though they were coming from the far end of a hallway. Her jugular veins were visibly distended at 45 degrees. Her blood pressure dropped further when she inhaled: a pulsus paradoxus of 18 mmHg.

Beck’s triad was present: hypotension, increased jugular venous pressure, muffled heart sounds. The bedside echocardiogram confirmed what the physical examination had already told me. There was a large circumferential pericardial effusion. The right atrium was collapsing during diastole. The inferior vena cava was plethoric, non-collapsing. This was cardiac tamponade.

The effusion had not come from nowhere. Malignant pericardial effusion is one of the most common causes of tamponade in patients with solid tumors. In breast cancer, pericardial involvement can be the first sign of recurrence. We did not know that yet. But the immediate problem was the pressure on her heart, and it needed to be relieved before anything else.

I explained what we were going to do. She would receive local anesthesia and sedation. A needle would be passed below the xiphoid process toward the heart, guided by echocardiography, into the pericardial space. A catheter would be left in place to drain the fluid. The procedure would relieve the pressure. Her blood pressure would likely improve within minutes of the first few hundred milliliters of drainage.

Forty-five minutes later, we had drained 1.1 liters of serosanguinous fluid. Her blood pressure was 118/76. Her heart rate was 88. She was breathing comfortably. She looked at the amount of fluid in the drainage bag and said, “That was in my heart?”

The pericardium holds the heart. When it fills with fluid, it does not give way. The pressure builds until the chambers cannot fill. The fluid we drained that day bought the time to determine what caused it and to plan what came next.

This article covers the anatomy of the pericardium, the physiology of tamponade, the procedure and its technique, the evidence, and the critical question of what happens after the fluid is drained.

At Carle Foundation Hospital in Urbana-Champaign, pericardiocentesis is performed in the cardiac catheterization laboratory with simultaneous hemodynamic monitoring and echocardiographic guidance, providing real-time confirmation of effusion location, needle position, and adequacy of drainage.

What It Is

Pericardiocentesis is the percutaneous removal of fluid from the pericardial space using a needle and catheter. It is both diagnostic (the fluid analysis identifies the cause of the effusion) and therapeutic (the drainage relieves the hemodynamic compression of cardiac tamponade or reduces symptoms from a large non-compressive effusion).

The pericardium: The pericardium is a fibrous double-walled sac enclosing the heart and the proximal great vessels. The outer fibrous pericardium is dense and relatively inelastic. The inner serous pericardium has two layers: the visceral layer (epicardium, adhered to the myocardial surface) and the parietal layer (lining the fibrous sac). The pericardial cavity between these two layers normally contains 15 to 50 mL of serous fluid, serving as lubricant.

Pericardial effusion: Excess fluid in the pericardial space. The hemodynamic significance depends on the rate and volume of fluid accumulation. The fibrous pericardium does not stretch acutely. A rapid accumulation of 150 to 200 mL can cause tamponade if the pericardium has had no time to stretch. A slow accumulation over weeks to months may reach 1 to 2 liters before producing hemodynamic compromise because the pericardium gradually accommodates the increasing volume. This is why the effusion size alone does not determine urgency; the echocardiographic signs of chamber compression and the patient’s hemodynamic status are the critical determinants.

Causes of pericardial effusion:

• Malignant effusion: Metastatic cancer (breast, lung, lymphoma, melanoma most common). Often large, often bloody. High recurrence rate after single drainage.
• Idiopathic pericarditis: Most common cause of acute pericarditis in developed countries. Presumably viral or post-viral immune-mediated. Usually small to moderate effusion.
• Infectious: Viral (coxsackievirus, echovirus), bacterial (purulent pericarditis, often requires surgical drainage), tuberculous (endemic in resource-limited settings; risk of constrictive pericarditis).
• Post-cardiac surgery or post-MI (Dressler syndrome): Autoimmune mechanism.
• Post-procedure: After cardiac surgery, ablation, pacemaker implant, coronary angiography.
• Autoimmune/inflammatory: Rheumatoid arthritis, lupus, vasculitis.
• Hypothyroidism: Often large effusion, rarely causes tamponade.
• Uremia: Pericardial effusion from end-stage renal disease; characteristic friction rub.
• Aortic dissection: Hemopericardium from Type A dissection is a surgical emergency, not a pericardiocentesis indication.

The Mechanism

Tamponade physiology: The pericardium is a closed, inelastic space. As fluid accumulates and intrapericardial pressure rises, it opposes the filling pressure in each cardiac chamber. Right atrial pressure (normally 0 to 5 mmHg) is overcome first; right atrial collapse during diastole is the earliest echocardiographic sign of hemodynamic compromise. As pressure continues to rise, right ventricular filling is impaired, then left atrial and ventricular filling. Stroke volume falls. Cardiac output falls. Blood pressure drops.

Ventricular interdependence in tamponade: With constrained pericardial space, inspiration increases right heart filling (as intrathoracic pressure drops and right ventricular filling improves), which shifts the interventricular septum to the left, compressing the left ventricle and reducing left ventricular filling and stroke volume. This exaggerates the normal inspiratory drop in blood pressure. A drop greater than 10 mmHg in systolic blood pressure with inspiration defines pulsus paradoxus, the clinical sign of hemodynamic tamponade 5 / Solid .

Equalization of filling pressures: As tamponade progresses, right atrial pressure, left atrial pressure, right ventricular diastolic pressure, and pericardial pressure converge toward a single increased value, typically 15 to 25 mmHg. This hemodynamic pattern is diagnostic when measured in the catheterization laboratory. Drainage produces an immediate fall in pericardial pressure, a separation of the filling pressures, and restoration of normal cardiac filling dynamics. The improvement in blood pressure and heart rate is typically seen within minutes of the first 100 to 300 mL of drainage.

Beck’s triad: The three classic clinical signs of acute cardiac tamponade:

1. Hypotension (low cardiac output)
2. Distended neck veins (increased central venous pressure)
3. Muffled heart sounds (fluid layer between myocardium and chest wall)

Beck’s triad is present in its complete form in approximately 30 to 40 percent of patients with acute tamponade. Subacute tamponade (from slowly accumulating effusion) often presents with a partial or incomplete triad. Echocardiography is more sensitive than clinical examination for diagnosing effusion and tamponade physiology 5 / Solid .

How It Is Used

Indications for pericardiocentesis:

• Tamponade: The primary emergency indication. Any effusion causing hemodynamic compromise (hypotension, increased JVP, echocardiographic evidence of chamber collapse) requires urgent drainage.
• Large effusion with symptoms: Dyspnea or chest pressure from a large effusion without frank tamponade may warrant elective drainage for symptom relief.
• Diagnostic drainage: When the cause of the effusion is unknown and the analysis will change management (suspected malignancy, tuberculosis, purulent pericarditis).

Contraindications:

• Aortic dissection with hemopericardium: Pericardiocentesis is contraindicated. Drainage without surgical control of the aortic tear will accelerate bleeding and cause death. Emergent cardiac surgery is the only appropriate intervention.
• Coagulopathy: Correct when possible; life-threatening tamponade may override this contraindication.
• Small posterior effusion not accessible from standard approach: Surgical drainage preferred.

Echocardiographic guidance: Ultrasound-guided pericardiocentesis is the current standard, having replaced the “blind” subxiphoid approach as the primary technique 5 / Solid 03006-7). The echocardiographer identifies the best available puncture site (the point on the chest wall where the effusion is largest and closest to the surface), measures the distance to the effusion, and provides real-time visualization of the needle entering the pericardial space. Agitated saline injected through the needle confirms intrapericardial position before catheter deployment.

Fluoroscopic guidance: In the cardiac catheterization laboratory, fluoroscopy guides wire and catheter positioning. Hemodynamic monitoring (right heart catheterization with pressure tracings) confirms equalization of filling pressures and the response to drainage. This combined approach is preferred in elective cases and complex effusions.

The subxiphoid approach: The traditional approach remains most commonly used. The needle enters the skin 1 to 2 cm inferior to the xiphoid process and is directed toward the left shoulder at approximately 45 degrees. The needle advances until it enters the pericardial space, confirmed by aspiration of fluid or echocardiographic visualization. A guidewire is then placed, the tract dilated, and a pigtail drainage catheter left in the pericardial space.

Drainage catheter versus single aspiration: For large malignant effusions or when recurrence is expected, a drainage catheter with drainage bag is left in place for 24 to 72 hours until drainage falls below 25 to 50 mL per day. This is more effective than single-needle aspiration alone at reducing recurrence in the short term. For post-procedural effusions or idiopathic pericarditis with moderate effusion, a single aspiration may be sufficient.

The Evidence

Diagnostic Yield of Pericardial Fluid Analysis

The diagnostic yield of pericardial fluid analysis depends on the underlying cause. A systematic review of 1,103 patients found the following diagnostic yields by etiology:

• Malignant effusion: cytology positive in 50 to 60 percent of cases; immunohistochemistry increases yield 5 / Solid 00978-3)
• Tuberculous pericarditis: culture sensitivity 50 percent; ADA (adenosine deaminase) greater than 40 U/L has 84 percent sensitivity and 83 percent specificity 5 / Solid
• Purulent pericarditis: Gram stain and culture; surgical drainage usually required
• Idiopathic: exudate; cells; no specific diagnosis in approximately 40 to 50 percent

Pericardial fluid analysis should include: appearance, glucose, protein, LDH (Light’s criteria for exudate vs transudate), cell count and differential, bacterial culture, AFB smear and culture, cytology, and ADA when tuberculosis is suspected.

Ultrasound Versus Blind Pericardiocentesis

A comparison of 1,127 pericardiocentesis procedures at the Mayo Clinic showed that echocardiography-guided pericardiocentesis had a major complication rate of 1.2 percent, compared with historical series of blind procedures with major complication rates of 2 to 10 percent 5 / Solid 00078-X). Major complications include pneumothorax, hemothorax, cardiac laceration, coronary artery laceration, and vasovagal reaction causing severe hypotension during the procedure.

Recurrence After Pericardiocentesis

Recurrence rates after pericardiocentesis depend on etiology:

• Malignant effusion: recurrence in 40 to 70 percent of patients after single drainage 5 / Solid 00078-X)
• Idiopathic pericarditis: low recurrence; colchicine plus NSAIDs reduces pericarditis recurrence 5 / Solid 60685-7)
• Post-cardiac surgery: often resolves after single drainage with underlying cause treated

Intrapericardial therapy: For malignant pericardial effusions with high recurrence risk, instillation of intrapericardial chemotherapy (cisplatin, thiotepa) or sclerosing agents (tetracycline) through the drainage catheter before removal may reduce recurrence. A randomized trial of intrapericardial cisplatin in malignant effusion showed a significantly lower recurrence rate at six months (10 percent vs 44 percent for drainage alone) in patients with non-small cell lung cancer 4 / Promising .

Surgical Drainage: Pericardiostomy and Window

Surgical pericardiocentesis (pericardial window) is preferred when:

• The effusion is loculated (cannot be reached percutaneously)
• Purulent pericarditis requires extensive drainage and debridement
• Concomitant cardiac surgery is planned
• Malignant effusion has recurred multiple times and a pericardial-pleural window would provide sustained drainage into the pleural space
• The patient has a posterior effusion that is not safely accessible from the standard anterior approach

A pericardial window can be created via subxiphoid approach under local anesthesia, via thoracoscopy (VATS), or via open thoracotomy. The subxiphoid approach has a lower morbidity profile and is preferred when surgery is needed for drainage alone 5 / Solid 90028-U).

Pericarditis Treatment and Recurrence Prevention

Acute idiopathic pericarditis responds to aspirin or NSAIDs plus colchicine. The COPE trial and ICAP trial both demonstrated that colchicine reduces the rate of incessant or recurrent pericarditis when added to standard anti-inflammatory therapy 5 / Solid 60685-7). The combination reduces recurrence from approximately 30 to 50 percent to 15 to 20 percent. Corticosteroids are reserved for patients with contraindications to aspirin/NSAIDs or colchicine, or for autoimmune-mediated pericarditis, and should not be used as first-line therapy for idiopathic pericarditis because they increase recurrence rates 5 / Solid .

The Patient Experience

The Emergency Scenario

Acute tamponade is a medical emergency. The patient experiencing tamponade typically presents with progressive dyspnea, lightheadedness, fatigue, and a feeling of chest fullness or heaviness. Blood pressure may be low but often holds until decompensation occurs rapidly. The diagnosis is confirmed by bedside echocardiography within minutes.

In the emergency setting, pericardiocentesis may be performed in the emergency department, ICU, or cardiac catheterization laboratory depending on the center. Local anesthesia is infiltrated below the xiphoid. Mild sedation is provided if the patient’s blood pressure permits. The procedure takes 15 to 30 minutes from the time the needle enters the skin. Hemodynamic improvement is often visible in real time: the blood pressure rises within minutes, heart rate drops, the patient often describes immediate relief of breathing difficulty.

The Elective Scenario

For a planned pericardiocentesis for a large symptomatic effusion or diagnostic drainage, the patient arrives fasting, undergoes anticoagulation review (warfarin and DOACs should be held), and receives preprocedural echocardiography to map the effusion. The procedure is typically performed in the cardiac catheterization laboratory. Duration is similar to the emergency setting; the difference is that the patient is more comfortable, the team less rushed, and the imaging more deliberate.

What Your Cardiologist Will Not Have Time to Explain

• The pericardial space does not care about the cause of the fluid. Draining it treats the pressure. Determining and treating the cause of the effusion is the work that follows the procedure.
• Pericardiocentesis does not prevent recurrence. If the underlying cause (malignancy, autoimmune disease, infection) is not treated, the fluid will return. Ask specifically: what is causing this effusion and what is the plan to address that cause?
• Not all large pericardial effusions need to be drained. A large effusion without tamponade physiology in a patient with chronic pericarditis and stable symptoms may be managed with anti-inflammatory treatment alone. The decision to drain is based on hemodynamics and cause, not size alone.
• “Bloody fluid” does not always mean malignancy. Post-procedural and post-radiation effusions, uremic effusions, and trauma can all produce bloody or serosanguinous pericardial fluid. Cytology is the definitive test for malignant cells.

Post-Procedure Care

A drainage catheter left in place requires monitoring for output volume, signs of catheter displacement, and signs of infection at the insertion site. Patients are admitted for observation. The catheter is removed when drainage falls below 25 to 50 mL in 24 hours (typically 24 to 72 hours after insertion for most malignant effusions). A post-removal echocardiogram confirms adequate drainage without recollection.

Sex Differences

Pericarditis and pericardial effusion prevalence does not show a strong sex predilection in most series. However, autoimmune-associated pericardial disease (lupus, rheumatoid arthritis, mixed connective tissue disease) is substantially more common in women, and the treatment of underlying autoimmune disease often reduces pericardial disease activity without requiring repeated drainage 4 / Promising . Pericardial involvement in breast cancer is the most common malignant pericardial effusion etiology in women and should be considered in any woman with prior breast cancer presenting with new pericardial effusion, even during apparent remission.

Geographic Access in Illinois

Emergency pericardiocentesis is performed at any hospital with cardiac catheterization or critical care capability. At Carle Foundation Hospital in Urbana-Champaign, pericardiocentesis is available in the cardiac catheterization laboratory with echocardiographic and fluoroscopic guidance. Complex malignant pericardial disease requiring intrapericardial therapy, recurrent drainage, or surgical pericardial window is managed through programs at Northwestern Medicine Bluhm Cardiovascular Institute and Rush University Medical Center in Chicago, where multidisciplinary oncology-cardiology collaboration is available.

Decisions and Trade-Offs

Percutaneous Versus Surgical Drainage

Percutaneous echocardiographically guided pericardiocentesis with catheter drainage is the standard first approach for accessible effusions. Surgical drainage (pericardial window) is preferred when:

• The effusion is posterior or loculated
• Malignant effusion has recurred and a pericardial-pleural window for sustained drainage is desired
• Purulent pericarditis with thick exudate requires surgical debridement
• Concomitant cardiac surgery for another indication is planned

The practical tradeoff is that surgical drainage requires anesthesia and thoracotomy or thoracoscopy, with higher short-term procedural risk than percutaneous drainage, but provides more definitive long-term drainage control in appropriate cases.

What to Do After the First Malignant Effusion

A malignant pericardial effusion recurs in 40 to 70 percent of patients after a single drainage. The options for recurrence prevention are:

1. Repeat pericardiocentesis when recurrence causes symptoms or hemodynamic compromise
2. Intrapericardial sclerosing or chemotherapy instillation at the time of initial drainage
3. Surgical pericardial window for sustained pericardial-pleural communication
4. Systemic treatment of the underlying malignancy (most important long-term strategy)

The choice depends on performance status, expected survival, and the trajectory of systemic cancer treatment. A patient who is actively responding to chemotherapy for breast cancer with a first malignant effusion may be best served by drainage, intrapericardial therapy, and continuation of systemic treatment. A patient with refractory malignancy and limited expected survival may be best served by a low-risk procedure (percutaneous drainage) focused on symptom relief rather than a surgical window.

Constrictive Pericarditis After Pericardiocentesis

Constrictive pericarditis is a late complication of pericardial inflammation and fibrosis. It occurs weeks to months after an initial episode of pericarditis or pericardial effusion in a small percentage of patients. The pericardium becomes thickened, calcified, and rigid, preventing normal diastolic expansion of the ventricles. Symptoms mimic right heart failure: increased JVP, edema, ascites, dyspnea. Echocardiographic findings include pericardial thickening, septal bounce, and exaggerated ventricular interdependence. The treatment is pericardiectomy (surgical removal of the pericardium). The risk of constriction after pericardiocentesis and anti-inflammatory treatment of idiopathic pericarditis is low (less than 1 percent for idiopathic pericarditis, higher for bacterial and tuberculous causes) 5 / Solid .

The Three Questions Every Patient Should Ask

1. “What is causing this fluid and what is the plan to prevent it coming back?” The procedure drains the fluid. The diagnosis determines whether it will return and what can be done to prevent it. Ask specifically whether cytology, ADA, and culture have been sent, and when results will be available. Ask what the plan is if a specific cause is identified.

2. “Should a catheter be left in, or was a single aspiration sufficient?” For large malignant or recurrent effusions, a catheter for 24 to 72 hours reduces early recurrence compared with single aspiration. For moderate post-procedural or idiopathic effusions, single aspiration with anti-inflammatory treatment may be adequate. The decision should be explicit.

3. “What symptoms should bring me back urgently?” Recurrence of dyspnea, return of chest pressure, light-headedness, or hypotension after pericardiocentesis may signal re-accumulation of fluid. Patients should know the symptoms of tamponade and have a clear pathway to access emergency evaluation if they develop them, without waiting for a scheduled follow-up appointment.

The SDE Synthesis

Pericardiocentesis is an intervention performed at a single point in time. What happens before and after that point is the clinical work that determines the outcome.

Before: identifying the cause of the effusion, assessing the hemodynamics, determining the urgency, and planning the approach. A large effusion found incidentally in an asymptomatic patient without tamponade physiology on echocardiography warrants investigation and monitoring, not automatic drainage.

After: determining the etiology, implementing targeted treatment for the underlying condition, monitoring for recurrence, and deciding whether additional interventions (pericardial window, intrapericardial therapy, systemic cancer treatment) are needed.

From the SDE Foundations perspective, pericardial disease is most commonly an expression of a systemic process: malignancy, autoimmune disease, infection, or post-procedural inflammation. The pericardiocentesis addresses the acute hemodynamic problem. The SDE Audit for a patient who has had pericardiocentesis reviews whether the underlying etiology has been identified, whether appropriate systemic treatment is in place, and whether the patient has a follow-up echocardiography plan.

For patients with cancer and malignant pericardial effusion, the SDE clinical framework emphasizes coordination between oncology and cardiology: the cardio-oncology intersection. The pericardial effusion does not exist separately from the cancer biology. Managing the effusion without managing the cancer, or managing the cancer without monitoring for cardiac complications, produces incomplete care.

For patients with recurrent idiopathic pericarditis and no malignant etiology, the SDE framework provides a structured approach to anti-inflammatory therapy including colchicine maintenance, monitoring for constrictive pericarditis as a late complication, and evaluation for autoimmune conditions that may be driving the recurrence.

Pericardiocentesis services with echocardiographic guidance are available at Carle Foundation Hospital in Urbana-Champaign. Patients with malignant pericardial disease requiring oncology-cardiology comanagement can be referred through the SDE network to Northwestern Medicine Bluhm Cardiovascular Institute and OSF Saint Francis Medical Center in Peoria, both of which maintain cardio-oncology programs.

Paired Foundations Articles:

• PROC-001: Cardiac Catheterization (hemodynamic confirmation of tamponade and post-drainage assessment)
• PROC-012: Cardiac MRI (pericardial thickening and constriction evaluation post-pericarditis)
• PROC-013: Stress Testing (post-pericarditis clearance assessment for return to activity)